Publication | Open Access

Modification of tumour blood flow using the hypertensive agent, angiotensin II

HypertensionAngiogenesisAngiotensin IiCardiovascular DiseaseMedicineAntihypertensive TherapyHypertensive AgentPharmacologyTumour Blood FlowVascular BiologyOncologyRadiation OncologyTumor MicroenvironmentTumor Biology